A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients’ quality of life. Tumor control was achieved in most participants, with urinary function (micturition) and sexual function largely maintained.
This article was originally published on MedicalXpress.com

